Medicine & Life Sciences
Acute Myeloid Leukemia
100%
Lymphoma, Large B-Cell, Diffuse
97%
Cell Transplantation
96%
Allogeneic Cells
82%
plerixafor octahydrochloride
81%
Transplants
70%
Decitabine
65%
Mantle-Cell Lymphoma
64%
Hodgkin Disease
60%
Stem Cell Transplantation
56%
Rituximab
55%
GATA2 Deficiency
51%
Hematopoietic Stem Cell Mobilization
50%
Survival
50%
Lymphoma
45%
Lenalidomide
44%
Cytarabine
42%
Granulocyte Colony-Stimulating Factor
41%
Stem Cells
41%
Myelodysplastic Syndromes
40%
Progression-Free Survival
39%
Tissue Donors
38%
Natural Killer Cells
38%
Drug Therapy
38%
Follicular Lymphoma
38%
Azacitidine
37%
Recurrence
36%
Bendamustine Hydrochloride
36%
Therapeutics
36%
Autologous Transplantation
36%
Interleukin-15
29%
belinostat
29%
Confidence Intervals
28%
Chimeric Antigen Receptors
27%
Hematopoietic Stem Cell Transplantation
26%
Peripheral Blood Stem Cells
25%
Leukemia
24%
Bone Marrow
23%
Peripheral T-Cell Lymphoma
23%
Non-Hodgkin's Lymphoma
23%
ALT-803
22%
PCI 32765
22%
Homologous Transplantation
21%
Hematopoietic Stem Cells
21%
T-Lymphocytes
21%
Cell- and Tissue-Based Therapy
21%
Neoplasms
20%
Graft vs Host Disease
20%
B-Cell Lymphoma
19%
B-Cell Chronic Lymphocytic Leukemia
19%